stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.48
0.53
+1.02%
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) Free cash flow
Heartflow, Inc.'s free cash flow for fiscal 2025 was −$59.0M, compared with −$73.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$59.2M. Heartflow, Inc. ranks 40th of 44 Health Information Services companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$59.0M | — |
| FY2024 | −$73.4M | — |
| FY2023 | −$82.5M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | −$10.5M | — |
| Mar 2026 | −$32.0M | — |
| Dec 2025 | −$12.5M | — |
| Sep 2025 | −$4.2M | — |
| 7 more quarters | Free account |
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| HQY HealthEquity, Inc. compare | $437.0M |
| DOCS Doximity, Inc. compare | $305.7M |
| HNGE Hinge Health Inc. compare | $283.9M |
| WAY Waystar Holding Corp. compare | $264.1M |
| OMCL Omnicell, Inc. compare | $132.7M |
| TDOC Teladoc Health, Inc. compare | $126.1M |
| PRVA Privia Health Group, Inc. compare | $108.1M |
| HTFL Heartflow, Inc. | −$59.2M |
| SDGR Schrodinger, Inc. compare | −$116.8M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on HTFL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement